Skip to content
2000
Volume 23, Issue 1
  • ISSN: 1570-1638
  • E-ISSN: 1875-6220

Abstract

Introduction

The search for potent anticancer agents has accelerated the evaluation of a wide variety of pharmacological scaffolds, including oxazole derivatives. Although they are currently underexplored, they are promising as anticancer agents. This research covers the synthesis and structure-activity relationships of oxazole-based compounds.

Methods

The authors designed and synthesized new oxazole derivatives and screened them for their anticancer activity using both computational and experimental methods. Molecular docking studies were performed to identify possible targets based on literature and the interaction of these molecules with anticancer targets like c-Kit tyrosine kinase (TRK) and Murine double minute 2 homolog (MDM2). The compounds were tested using the MTT assay on a cancer cell lines, MCF-7, to evaluate their potential effectiveness.

Results and Discussion

Robust synthetic procedures were developed and optimized for oxazole-based Schiff bases, with their structures confirmed through spectral analyses. Four compounds demonstrated significantly higher anticancer efficacy, while one has lesser potency, suggesting some Structure-Activity Relationship (SAR) nuances within the series. The biological activities (IC) were determined to be in the range of 80-100 µg/mL, while molecular docking indicated that compound 4c could serve as a potential lead for c-Kit Tyrosine Kinase (TRK) inhibition.

Conclusion

The results obtained from the present study corroborate the hypothesis that oxazole derivatives are potent anticancer agents, consistent with predictions from molecular docking studies. These findings highlight the significance of the oxazole scaffold in anticancer drug discovery and encourage further exploration of structure-activity relationships to enhance therapeutic potential. Although compound 4c showed better interactions in docking studies it turned out to be less effective in biological screening, this suggests that pharmacokinetic issues should be addressed. Future studies are likely to include models and detailed mechanistic evaluations to validate these findings and support the development of oxazole-derived anticancer compounds.

© 2026 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/cddt/10.2174/0115701638370100250527073704
2025-06-10
2026-03-08

  • From This Site

    /content/journals/cddt/10.2174/0115701638370100250527073704
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. LiuL. LiuW. Ring expansion strategy to access functionalized 2-oxazolines (microreview).Chem. Heterocycl. Comp.202460523623810.1007/s10593‑024‑03326‑y
     [Google Scholar]
  2. ChiacchioM.A. LanzaG. ChiacchioU. Oxazole-based compounds as anticancer agents.Curr. Med. Chem.202026417337737110.2174/0929867326666181203130402 30501590
     [Google Scholar]
  3. LiuX-H. LvP-C. XueJ-Y. SongB-A. ZhuH-L. Novel 2,4,5-trisubstituted oxazole derivatives: Synthesis and antiproliferative activity.Eur. J. Med. Chem.2009441039303935 19423198
     [Google Scholar]
  4. MahalK. BiersackB. SchobertR. New oxazole-bridged combretastatin A-4 analogues as potential vascular-disrupting agents.Int. J. Clin. Pharmacol. Ther.20135114143 23259996
     [Google Scholar]
  5. ApostolT-V. MarutescuL.G. DraghiciC. Synthesis and biological evaluation of new N-Acyl-α-amino Ketones and 1,3-Oxazoles derivatives.Molecules202126165019 34443608
     [Google Scholar]
  6. ChengX. XuZ. LuoH. ChangX. LvX. Design, synthesis, and biological evaluation of novel pyrazol-5-yl-benzamide derivatives containing oxazole group as potential succinate dehydrogenase inhibitors.J. Agric. Food Chem.20227043138391384810.1021/acs.jafc.2c04708 36270026
     [Google Scholar]
  7. García-RamírezV.G. Suarez-CastroA. Villa-LopezM.G. Díaz-CervantesE. Chacón-GarcíaL. Cortes-GarcíaC.J. Synthesis of novel acylhydrazone-oxazole hybrids and docking studies of SARS-CoV-2 main protease.Chem Proc202031110.3390/ecsoc‑24‑08329
     [Google Scholar]
  8. WangM. LiL. YangS. Synthesis of novel oxazol-5-one derivatives containing chiral trifluoromethyl and isoxazole moieties as potent antitumor agents and the mechanism investigation.J Bioorganic Chemistry2023135106505 37027950
     [Google Scholar]
  9. Molecular Operating Environment (MOE). 2024. Available from: https://www.chemcomp.com/en/index.htm
  10. Abd-ElzaherM.M. LabibA.A. MousaH.A. MoustafaS.A. AliM.M. El-RashedyA.A. Synthesis, anticancer activity and molecular docking study of Schiff base complexes containing thiazole moiety.Beni. Suef Univ. J. Basic Appl. Sci.2016518596
     [Google Scholar]
  11. SaidM.A. Al-HarbiW.S. ShanmugamM. AljohaniF.S. BouqellahN.A. Al-KaffN.S. Synthesis, XRD, HAS, in silico molecular docking studies and biological assessment of novel Schiff base compounds as anti-cancer and antimicrobial agents.J. Taibah Univ. Sci.202014115901603
     [Google Scholar]
  12. MosmannT. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays.J. Immunol. Methods1983651-25563 6606682
     [Google Scholar]
  13. HansenM.B. NielsenS.E. BergK. Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill.J. Immunol. Methods19891192203210 2470825
     [Google Scholar]
  14. CytotoxicityA.P.W. Cytotoxicity and Viability Assays in Animal Cell Culture: A practical Approach.OxfordUniversity Press2000
     [Google Scholar]
  15. AlizadehS.R. HashemiS.M. Development and therapeutic potential of 2-aminothiazole derivatives in anticancer drug discovery.Med. Chem. Res.202130477180610.1007/s00044‑020‑02686‑2 33469255
     [Google Scholar]
  16. RobinsonR. CCXXXII.-A new synthesis of oxazole derivatives.J. Chem. Soc. Trans.1909952167217410.1039/CT9099502167
     [Google Scholar]
  17. GabrielS. Eine Synthese von Oxazolen und Thiazolen. I.Eur. J. Inorg. Chem.191043113413810.1002/cber.19100430117
     [Google Scholar]
  18. GhodgaonkarS. KulkarniV.V. WaghuldeS.O. LaddhaS.S. ShahJ. Synthesis and Evaluation of Novel Thiazole Derivatives.International Electronic Conference on Synthetic Organic ChemistryBasel, Switzerland1-30 November 201010.3390/ecsoc‑14‑00397
     [Google Scholar]
/content/journals/cddt/10.2174/0115701638370100250527073704
Loading
Exploring Novel Oxazole Derivatives for Cancer Therapy: Design, Synthesis, and Mechanistic Insights
Current Drug Discovery Technologies 23, e15701638370100 (2026); https://doi.org/10.2174/0115701638370100250527073704
/content/journals/cddt/10.2174/0115701638370100250527073704
/content/journals/cddt/10.2174/0115701638370100250527073704
Loading

Data & Media loading...

Supplements

Supplementary material is available on the publisher’s website along with the published article.

file format download Download

  • Article Type:     Research Article
Keyword(s): anticancer; c-Kit tyrosine kinase (TRK); Molecular docking; MTT assay; Oxazole; schiff base synthesis

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test